This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción DSH
Sensyne Health plc, a healthcare technology company, develops software products that connects healthcare professionals with patients in the United Kingdom and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de Sensyne Health plc
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.006 |
| 52 Week High | UK£1.81 |
| 52 Week Low | UK£0.006 |
| Beta | 1.2 |
| 1 Month Change | -57.14% |
| 3 Month Change | -95.08% |
| 1 Year Change | -99.63% |
| 3 Year Change | -99.58% |
| 5 Year Change | n/a |
| Change since IPO | -99.74% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| DSH | DE Healthcare Services | Mercado DE | |
|---|---|---|---|
| 7D | -25.0% | 1.1% | -0.5% |
| 1Y | -99.6% | -24.7% | 2.5% |
Rentabilidad vs. Industria: DSH underperformed the German Healthcare Services industry which returned -32.5% over the past year.
Rentabilidad vs. Mercado: DSH underperformed the German Market which returned -20.7% over the past year.
Volatilidad de los precios
| DSH volatility | |
|---|---|
| DSH Average Weekly Movement | 30.5% |
| Healthcare Services Industry Average Movement | 3.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: DSH's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: DSH's weekly volatility has increased from 19% to 31% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2018 | 158 | Alex Snow | www.sensynehealth.com |
Resumen de fundamentos de Sensyne Health plc
| Estadísticas fundamentales de DSH | |
|---|---|
| Capitalización bursátil | €677.46k |
| Beneficios(TTM) | -€40.50m |
| Ingresos (TTM) | €9.08m |
0.1x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está DSH sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DSH | |
|---|---|
| Ingresos | UK£7.81m |
| Coste de los ingresos | UK£2.78m |
| Beneficio bruto | UK£5.03m |
| Otros gastos | UK£39.86m |
| Beneficios | -UK£34.83m |
Últimos beneficios comunicados
Oct 31, 2021
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.21 |
| Margen bruto | 64.37% |
| Margen de beneficio neto | -446.13% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado DSH a largo plazo?
Ver rendimiento histórico y comparativa